Cytokinetics's total assets for Q2 2026 were $1.92B, an increase of 51.13% from the previous quarter. DE:KK3A total liabilities were $2.10B for the fiscal quarter, a -0.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.